Explain When Injectable Hydromorphone Might Be Used for Opioid Use Disorder
July 2019
Canada is the first country to approve injectable hydromorphone (Hydromorphone HP) for severe opioid use disorder.
These are patients with multiple challenging symptoms...long-term high-dose opioid use, need for increasing amounts for fulfillment, social and occupational impacts, etc.
First-line oral methadone and buprenorphine/naloxone (Suboxone) don't always work for these patients. For example, sometimes the PROCESS of injecting helps manage withdrawal symptoms.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive